Townson Sharon — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Townson Sharon has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $424K.

Profile

Sharon Townson serves as Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (ticker GLUE) as disclosed in the company's SEC filings. In this role, she leads Monte Rosa's scientific strategy and development efforts for molecular glue degraders within the QuEEN platform, guiding discovery and preclinical programs.

Board memberships

• Monte Rosa Therapeutics, Inc. (GLUE)

Awards & honors

• Leading scientific strategy for molecular glue degrader programs at Monte Rosa Therapeutics
• Overseeing the QuEEN platform's target discovery and preclinical efforts
• Building and guiding cross-disciplinary teams in oncology and protein degradation

Recent Transactions

Companies — Last 90 Days

• Monte Rosa Therapeutics, Inc. (GLUE) — 4 filings, last 2026-07-07

Frequently Asked Questions

Who is Townson Sharon?

Sharon Townson serves as Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (ticker GLUE) as disclosed in the company's SEC filings. In this role, she leads Monte Rosa's scientific strategy and development efforts for molecular glue degraders within the QuEEN platform, guiding discovery and preclinical programs.…

How many SEC Form 4 filings has Townson Sharon submitted recently?

4 primary Form 4 filings in the last 90 days, covering 1 company.

Has Townson Sharon been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($424K) across all tracked filings.

Where can I see all of Townson Sharon's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week